Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-3 of 3 for your search:
Drug:
BB-10901
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I Study of BB-10901 in Patients With Relapsed or Refractory Small Cell Lung Cancer, Other Pulmonary Tumors of Neuroendocrine Origin, Non-Pulmonary Small Cell Carcinoma, Metastatic Carcinoid Tumors, or Other CD56-Positive Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
IMMUNO-C10/IVB/002
, IMMUNO-002, MDA-2004-0557, NCT00346385
2.
Phase I Study of BB-10901 in Patients With Relapsed and/or Refractory CD56-Positive Multiple Myeloma
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
IMMUNO-003
, DFCI-05031, NCT00346255
3.
IMGN901 in Combination With Lenalidomide and Dexamethasone
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
IMGN0005
, NCT00991562
Select All on Page
Help with Results
